US Patent Issued to INDIVIOR UK on May 12 for "Buprenorphine dosing regimens" (Virginia Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,904, issued on May 12, was assigned to INDIVIOR UK Ltd. (Hull, Great Britain).

"Buprenorphine dosing regimens" was invented by Azmi Nasser (North Chesterfield, Va.), Celine M. Laffont (North Chesterfield, Va.) and Christian A. Heidbreder (North Chesterfield, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a dosage regimen using sustained-release buprenorphine formulations to produce therapeutic levels of buprenorphine in patients for the treatment of pain or opioid use disorders."

The patent was filed on March 20, 2025, under Application No. 19/085,650.

*For further information, including images, charts and tables, please...